VRTX Operating Expenses

Vertex Pharmaceuticals · Operating Expenses

VRTX logo

VRTX Operating Expenses

Latest reported$1.60B
VRTX Quarterly Operating Expenses ($0.00 → $1.60B)
High-resolution chart · PNG

VRTX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
1,597,800,000
1,456,000,000
1,460,700,000
1,475,400,000
1,406,100,000
1,777,100,000
1,462,600,000
1,263,000,000
5,788,400,000
1,208,500,000
1,161,200,000
1,125,500,000
1,158,800,000
1,328,900,000
985,900,000
918,200,000
828,100,000
810,800,000
949,500,000
691,940,000
1,603,300,000
648,050,000
678,427,000
678,048,000
621,932,000
630,786,000
675,288,000
715,622,000
535,593,000
486,535,000
591,091,000
467,805,000
474,835,000
440,361,000
441,458,000
575,657,000
416,700,000
386,889,000
358,360,000
381,425,000
382,660,000
361,074,000
407,483,000
346,056,000
318,252,000
301,459,000
279,990,000
266,163,000
302,226,000
313,175,000
324,797,000
316,371,000
328,976,000
310,974,000
323,561,000
297,845,000
314,058,000
307,517,000
308,319,000
299,706,000
270,267,000
230,135,000
231,366,000
219,289,000
195,997,000
178,564,000
167,804,000
168,704,000
171,857,000
172,101,000
168,818,000
157,158,000
156,021,000
136,205,000
138,792,000
150,365,000
159,509,000
149,115,000
124,984,000
110,888,000
105,620,000
88,081,000
80,969,000
74,328,000
70,171,000
67,062,000
65,904,000
59,390,000
57,610,000
51,397,000
122,909,000
59,558,000
105,045,000
-112,000
70,847,000
63,550,000
59,894,000
58,117,000
55,018,000
50,107,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.